CAS:404951-53-7   2-Propenamide, N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-, (2E)-
CAS:404951-53-7   2-Propenamide, N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-, (2E)-
+
  • CAS:404951-53-7   2-Propenamide, N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-, (2E)-
  • CAS:404951-53-7   2-Propenamide, N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-, (2E)-

CAS:404951-53-7 2-Propenamide, N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-, (2E)-

NAME:2-Propenamide, N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-, (2E)- CAS:404951-53-7 MF:C22H25N3O3 MW:379.45 PURITY:98%

Categories:

Material Chemistry

Product introduction

NAME 2-Propenamide, N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-, (2E)-
CAS 404951-53-7
MF C22H25N3O3
MW 379.45
DENSITY 1.290±0.06 g/cm3
MP  
BP  
STORAGE Store at -20°C    

Description
Chemical Reactions Analysis
Dacinostat has been shown to increase SMN2 transcript and protein levels and promote demethylation of the SMN2 gene . It has also been observed to tackle cancer chemoresistance in multiple myeloma and acute myeloid leukemia .

Key words:

Related Products

Related Products

Inquiry

SUBMIT